Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2019

Sep 11, 2019

3358_rns_2019-09-11_7800c459-6554-4045-82ac-b6410a230e7f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Coloplast

Ostomy Care

Continence Care

Wound & Skin Care

Interventional Urology

Nasdaq Copenhagen

11 September 2019

Coloplast A/S

Holtedam 1

3050 Humlebæk

Denmark

Tlf: +45 4911 1111

www.coloplast.com

CVR-nr. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns purchase of shares.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Gerda Louis-Hansen
2 Reason for the notification
a) Position/status Related party to Niels Peter Louis Hansen (member of the board)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code B shares
ISIN: DK0060448595
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volumes(s)
761.20 23
761.20 32
761.20 9
760.60 4
760.60 1
760.60 31
760.60 5
760.60 4
760.60 5
760.60 5
760.60 85
760.60 1
760.60 2

Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Interventional Urology

760.60 14
760.60 3
760.60 7
760.60 5
760.60 35
760.80 191
760.60 2
760.60 3
760.60 2
760.60 3
760.60 54
760.60 5
760.60 87
760.60 46
760.60 2
760.60 46
760.60 3
760.60 9
760.60 74
760.60 3
760.60 17
760.40 178
759.20 213
759.20 211
759.20 302
758.80 12
758.80 45
758.80 75
758.80 45
758.80 75
758.80 45
758.80 19
758.80 8
758.80 12
758.80 3
759.40 31
759.40 30
759.40 15
759.40 1
759.40 13

Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Interventional Urology

759.40 1
759.40 2
759.40 200
759.40 30
759.40 31
759.40 29
759.40 8
759.40 13
759.40 2
759.30 126
760.00 6
760.00 37
760.00 6
760.00 6
760.00 90
760.00 36
760.00 1
760.00 23
760.00 31
760.00 8
760.00 10
760.00 6
760.00 11
760.00 44
760.00 14
760.00 17
759.30 137
759.00 53
759.00 19
759.00 137
759.00 55
759.20 22
759.20 102
759.20 27
759.20 64
759.20 15
759.20 29
759.20 35
759.20 24
759.20 9

Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Interventional Urology

759.20 24
759.20 11
759.20 68
759.20 8
759.00 22
759.00 6
759.20 74
758.80 14
758.80 1
758.80 8
d) Aggregated information
- Aggregated volume
- Price 3,900 shares
DKK 759.61 (volume weighted average)
e) Date of the transaction 2019-09-10, 13:10 UTC (last trade)
f) Place of the transaction Nasdaq Copenhagen A/S (XCSE)

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Anne-Sofie Søegaard, tel.: +45 4911 1924